Skip to content

13F-HR filed by Hudson Executive Capital LP

Hudson Executive Capital LP filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 7 holding rows worth $217,580,000.

Accession
0001214659-17-005088
Filed
2017-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2017

A holdings report, 7 entries on the cover page, a total value of $217,580,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $217,580,000 with VALUE read as thousands by filing date, 13F file number 028-17089. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
EAGLE PHARMACEUTICALS INC269796108COM950,600$74,993,000thousands by filing date
CIT GROUP INC COM NEW125581801Stock1,070,857$52,151,000thousands by filing date
ATRICURE INC04963C209COM1,855,000$44,984,000thousands by filing date
CORINDUS VASCULAR ROBOTICS I218730109COM11,336,154$21,085,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM773,090$15,230,000thousands by filing date
MAGELLAN HEALTH SERVICES INC559079207COM NEW98,700$7,195,000thousands by filing date
MERIDIAN BIOSCIENCE INC589584101COMMON STOCK123,300$1,942,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-17-005088this filing2017-08-14acceptance time not in the bulk data set